reviewNature Reviews NeurologyDec 1, 2017Closed access

Antisense oligonucleotides: the next frontier for treatment of neurological disorders

CRCarlo RinaldiMJMatthew J. A. Wood

University of Oxford

Indexed incrossref

Abstract

No abstract available for this paper.

Citation impact

778
total citations
FWCI
27.02
Percentile
100%
References
202
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Spinal muscular atrophy
  • Medicine
  • Duchenne muscular dystrophy
  • Antisense therapy
  • Disease
  • Oligonucleotide
  • Exon skipping
  • Clinical trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.